ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,688.33
1.27%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Krystal Biotech Inc (KRYS)

  7. Krystal Biotech Inc (KRYS) ニュース

KRYS Krystal Biotech Inc

161.10
0.87 (0.54%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Krystal Biotech Inc KRYS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.87 0.54% 161.10 09:00:00
始値 安値 高値 終値 前日終値
163.55 157.895 164.74 161.10 160.23
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0220:00GLOBEKrystal Biotech to Present at the Association for Research..
2024/4/2620:00GLOBEKrystal Biotech to Report First Quarter 2024 Financial..
2024/4/2220:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
2024/4/0420:00GLOBEKrystal Biotech to Present at the American Association..
2024/3/0210:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0210:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2911:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2821:00GLOBEKrystal Biotech to Present at TD Cowen 44th Annual Health..
2024/2/2703:35EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2622:04EDGAR2Form 8-K - Current report
2024/2/2622:00GLOBEKrystal Biotech Announces Fourth Quarter and Full Year 2023..
2024/2/2621:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2621:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2619:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
2024/2/2021:00GLOBEKrystal Biotech to Report Fourth Quarter and Full Year 2023 ..
2024/2/1321:00GLOBEKrystal Biotech Receives FDA Fast Track Designation for..
2024/2/0821:00GLOBEKrystal Biotech Announces Publication in the New England..
2024/2/0121:00GLOBEKrystal Biotech to Present at Guggenheim 6th Annual..
2024/1/2507:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2301:43EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0421:00GLOBEKrystal Biotech Receives Permanent J-code (J3401) for..
2023/12/1921:00GLOBEKrystal Biotech Receives Orphan Drug Designation from the..
2023/11/2721:00GLOBEKrystal Biotech Announces EMA Validation of Marketing..
2023/11/0921:00GLOBEKrystal Biotech to Present at the Stifel 2023 Healthcare..
2023/11/0621:10EDGAR2Form 8-K - Current report
2023/11/0621:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0621:00GLOBEKrystal Biotech Announces Third Quarter 2023 Financial..
2023/10/3020:00GLOBEKrystal Biotech to Report Third Quarter 2023 Financial..
2023/10/0301:07EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2820:00GLOBEKrystal Biotech to Present at the Chardan 7th Annual Genetic..
2023/9/0720:00GLOBEKrystal Biotech to Present at the Morgan Stanley 21st Annual..
2023/9/0520:00GLOBEKrystal Biotech Announces Orphan Drug Designation Granted to..
2023/8/2206:30EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1705:57EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1605:56EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1205:39EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1107:06EDGAR2Form 144 - Report of proposed sale of securities
2023/8/0721:18EDGAR2Form 8-K - Current report
2023/8/0720:13EDGAR2Form 8-K - Current report
2023/8/0720:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0720:00GLOBEKrystal Biotech Announces Second Quarter 2023 Financial..
2023/7/2705:14GLOBEKrystal Biotech Announces Pipeline Expansion into Oncology..
2023/7/2705:01EDGAR2Form 8-K - Current report
2023/7/1905:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/7/1105:01GLOBEArbutus Appoints Two New Executives
2023/7/0405:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0405:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0405:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0320:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
2023/6/0520:00GLOBEKrystal Biotech to Present at Upcoming Investor Conferences

最近閲覧した銘柄

NASDAQ
KRYS
Krystal Biotech
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有